Differential retinal angiogenic response to sustained intravitreal release of VEGF and bFGF in different pigmented rabbit breeds

Purpose. To determine if two different breeds of pigmented rabbits can demonstrate differences in the degree of inducible angiogenesis within the retina. Methods. Non-biodegradable Hydron pellets approximately 1.5mm in diameter containing both vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) were implanted intravitreally over the optic disk of either Dutch belt rabbits or New Zealand White/Black satin cross rabbits. Control animals from both groups were implanted with blank Hydron pellets. Animals were examined periodically over a 30-day period following implantation. Results were documented by fundus photography and flourescein angiography. Stages of neovascularization (NV) were graded between +1 (preproliferative) and +4 (total NV) with +5 for NV complicated by hemorrhage and/or retinal detachment. Results. The angiogenic response in the retinas of pigmented NZW/Black satin cross rabbits (N = 5) following implantation of VEGF/bFGF-containing pellets varied extensively from the Dutch belt animals (N = 7). In the Dutch belt rabbits, grading of the angiogenic response demonstrated either +4 or +5 between day 20 and day 30 after implantation. In contrast, the NZW/Black satin cross animals gave a more muted response with a maximum grade of +2 following exposure to the same amount of VEGF and bFGF. Control eyes that received only blank pellets showed no evidence of retinal NV in either the Dutch belts (N = 5) or the NZW/Black satin cross rabbits (N = 5). Statistical analysis showed a significant interaction effect for breed and pellet type (F = 44.85 with 1df, p < 0.00005), indicating a difference between the breeds in the angiogenic response to the pellet. Moreover, both the NZW/BSC and Dutch belt rabbits displayed a significant increase in angiogenesis with the VEGF/bFGF pellet in comparison to the blank pellet (p = 0.037 and p < 0.00005, respectively). Conclusions. These studies indicate that two different breeds of pigmented rabbits exhibit different angiogenic responses to the same amount of both VEGF and bFGF. Florid retinal NV leading to hemorrhage, fibrovascular membrane formation, and traction retinal detachment occurred in the Dutch belt rabbits while tortuosity and dilatation of existing blood vessels with subsequent regression occurred in the NZW/ Black satin cross animals. Such differences in the angiogenic response may be due to differences in the genetic background of these animals. If genetic heteriogeneity exists for angiogenic responses, then understanding the genetic role in the regulation of angiogenesis will lead to the design of more effective anti-angiogenic agents and can provide predictive outcomes of individual responses to therapy.

[1]  M. Musarella Molecular genetics of macular degeneration , 2001, Documenta Ophthalmologica.

[2]  U. Schraermeyer,et al.  Retinal pigment epithelial cells: autocrine and paracrine stimulation of extracellular matrix contraction , 1997, Graefe's Archive for Clinical and Experimental Ophthalmology.

[3]  S. Ross,et al.  Genetic risk factors in diabetic retinopathy , 1993, Diabetologia.

[4]  J. Cunha-Vaz,et al.  Novel imaging techniques for diabetic macular edema , 2004, Documenta Ophthalmologica.

[5]  M. Berns,et al.  Bioengineering Retinal Blood Vessels with Pro-Angiogenic Polymeric Scaffolds , 2002 .

[6]  R. Klein,et al.  HLA-DR3 and DR4 and their relation to the incidence and progression of diabetic retinopathy. , 2002, Ophthalmology.

[7]  Franklin Peale,et al.  Identification of an angiogenic mitogen selective for endocrine gland endothelium , 2001, Nature.

[8]  P. Campochiaro,et al.  Pigment epithelium‐derived factor inhibits retinal and choroidal neovascularization , 2001, Journal of cellular physiology.

[9]  A Erginay,et al.  Reproducibility of retinal mapping using optical coherence tomography. , 2001, Archives of ophthalmology.

[10]  G. Desoye,et al.  Differential mitogenic responses of human macrovascular and microvascular endothelial cells to cytokines underline their phenotypic heterogeneity , 2001, Cell proliferation.

[11]  M. Votruba,et al.  Neovascular age-related macular degeneration: Present and future treatment options , 2001, Eye.

[12]  M. Boulton,et al.  The role of the retinal pigment epithelium: Topographical variation and ageing changes , 2001, Eye.

[13]  Michael W. Berns,et al.  Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit , 2001, Current eye research.

[14]  S. Chakrabarti,et al.  Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy , 2000, Diabetes/metabolism research and reviews.

[15]  L. Aiello,et al.  Role of vascular endothelial growth factor in diabetic vascular complications. , 2000, Kidney international. Supplement.

[16]  R. D'Amato,et al.  Genetic heterogeneity of angiogenesis in mice , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  P. Campochiaro,et al.  The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration. , 1999, Molecular vision.

[18]  W. Benedict,et al.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. , 1999, Science.

[19]  S. Bressler,et al.  Age-related macular degeneration and risk factors for the development of choroidal neovascularization in the fellow eye. , 1998, Current opinion in ophthalmology.

[20]  Zhongping Chen,et al.  Optical Doppler Tomography: Imaging in vivo Blood Flow Dynamics Following Pharmacological Intervention and Photodynamic Therapy , 1998, Photochemistry and photobiology.

[21]  P. Campochiaro,et al.  Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. , 1998, Experimental eye research.

[22]  Weiheng Chen,et al.  Production of platelet-derived growth factor by interleukin-1 beta and transforming growth factor-beta-stimulated retinal pigment epithelial cells leads to contraction of collagen gels. , 1997, Investigative ophthalmology & visual science.

[23]  Einar Stefánsson,et al.  Retinal vessel dilatation and elongation precedes diabetic macular oedema , 1997, The British journal of ophthalmology.

[24]  B. Saville,et al.  Drug distribution in the vitreous humor of the human eye: the effects of intravitreal injection position and volume. , 1997, Current eye research.

[25]  Joan W. Miller,et al.  Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. , 1996, Ophthalmology.

[26]  Å. Lernmark,et al.  HLA-DQB1*0201/0302 is associated with severe retinopathy in patients with IDDM , 1996, Diabetologia.

[27]  T. Huang,et al.  Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom. , 1996, Investigative ophthalmology & visual science.

[28]  L. Aiello,et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.

[29]  P. D'Amore,et al.  Mechanisms of retinal and choroidal neovascularization. , 1994, Investigative ophthalmology & visual science.

[30]  S. Wahab Traction retinal detachment. XLIX Edward Jackson Memorial Lecture. , 1994, American journal of ophthalmology.

[31]  Z. Gregor,et al.  Cytokeratin-containing cells in proliferative diabetic retinopathy membranes. , 1994, The British journal of ophthalmology.

[32]  J. Folkman,et al.  Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy , 1995 .

[33]  D Verma,et al.  Pathogenesis of diabetic retinopathy--the missing link? , 1993, Medical hypotheses.

[34]  L. Mandarino Current Hypotheses for the Biochemical Basis of Diabetic Retinopathy , 1992, Diabetes Care.

[35]  K. Skorecki,et al.  Promoter region of the murine fibroblast growth factor receptor 2 (bek/KGFR) gene. , 1992, Oncogene.

[36]  B. Glaser,et al.  Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction. , 1987, Ophthalmology.

[37]  W. Tasman,et al.  Cryotherapy for active retinopathy of prematurity. , 1986, Ophthalmology.

[38]  Z. Gregor,et al.  Senile macular changes in the black African. , 1978, The British journal of ophthalmology.

[39]  R Hiller,et al.  Blindness caused by diabetic retinopathy. , 1974, American journal of ophthalmology.